Advances in deep vein thrombosis treatment.

Research output: Contribution to journalReview articlepeer-review


Venous and arterial thromboses account for some of the most common causes of morbidity and mortality amongst patients in the United States and many other Western societies. Clotting disorders and hypercoagulable states are no longer just treated by hematologist, but by multiple specialties including internal medicine, family practice, critical care physicians and most recently, hospitalists. In more than 75% of cases, the cause of the thrombotic episodes can be identified. More than one-half of the patients with thrombosis harbor either congenital propensity to develop a thrombosis, or have an acquired event that precipitates a pro-thrombotic state.

Original languageEnglish (US)
Pages (from-to)249-253
Number of pages5
JournalSurgical technology international
StatePublished - Jan 1 2002

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Advances in deep vein thrombosis treatment.'. Together they form a unique fingerprint.

Cite this